— Know what they know.
Not Investment Advice

ZYME NASDAQ

Zymeworks Inc.
1W: +4.8% 1M: -12.0% 3M: +10.5% YTD: -5.7% 1Y: +102.0% 3Y: +178.1% 5Y: -12.2%
$25.61
+0.50 (+1.99%)
After Hours: $24.60 (-1.01, -3.94%)
Weekly Expected Move ±6.9%
$21 $22 $24 $26 $27
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 36 · $1.9B mcap · 68M float · 0.983% daily turnover · Short 62% of daily vol

Cash Flow Trends

Operating Cash Flow
-$33M +70.0% ▲
Capital Expenditures
$2M +50.4% ▲
5Y CAGR: -24.7%
Free Cash Flow
-$35M +69.5% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$42M -38.7% ▼
Net Change in Cash
-$25M +72.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$212M$124M-$119M-$123M-$81M
Depreciation & Amort.$10M$12M$17M$11M$11M
Stock-Based Comp.$11M$4M$8M$18M$28M
Change in Working Capital$393K$4M-$26M-$31M$8M
Other Non-Cash Items-$387K-$2M$1M$14M$848K
Operating Cash Flow-$192M$144M-$118M-$110M-$33M
— Investing Activities —
Capital Expenditures-$12M-$13M-$2M-$2M-$2M
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$35M-$41M-$553M-$284M-$196M
Investment Sales$193M-$41M$350M$326M$225M
Other Investing-$881K$41M-$2M-$1M$0
Investing Cash Flow$145M-$54M-$207M$39M$27M
— Financing Activities —
Net Debt Issuance-$17K-$14K-$21K-$14K$0
Stock Repurchased$0$0$0-$30M-$42M
Dividends Paid$0$0$0$0$0
Other Financing$8M$1M$6M$10M-$181K
Financing Cash Flow$8M$109M$82M-$20M-$19M
Net Change in Cash-$40M$199M-$243M-$91M-$25M
Cash End of Period$202M$401M$158M$66M$41M
Free Cash Flow-$206M$131M-$122M-$113M-$35M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms